3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Lymphoma
3
Neoplasms
2
Brain Neoplasms
2
Spinal Cord Neoplasms
1
Neoplasm Metastasis
1
Central Nervous System Neoplasms
1
Interventions
Temozolomide
3
veliparib
1
romidepsin
1
perillyl alcohol
1
lonafarnib
1
ispinesib
1
etoposide phosphate
1
emvododstat
1
cediranib
1
Vorinostat
1
Vincristine
1
Valproic Acid
1
Thiotepa
1
Therapeutics
1
RRx-001
1
Peripheral Blood Stem Cell Transplantation
1
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
1
Melphalan
1
Irinotecan
1
Infusions, Intra-Arterial
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Drug Therapy
1
Dexamethasone
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
Calcium Dobesilate
1
CK0238273
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Spinal Cord Neoplasms
×
RRx-001
×
Clear all
NCT04525014
2024-10-31
PIRATE
EpicentRx, Inc.
Phase 1
Terminated
2 enrolled